Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
Nirav N. Shah(Medical College of Wisconsin), Bryon D. Johnson(Medical College of Wisconsin), Dina Schneider(Lentigen Technology (United States)), Fenlu Zhu(Medical College of Wisconsin), Anikó Szabó(Medical College of Wisconsin), Carolyn A. Keever-Taylor(Medical College of Wisconsin), Winfried Krueger(Lentigen Technology (United States)), Andrew Worden(Lentigen Technology (United States)), Michael J. Kadan(Lentigen Technology (United States)), Sharon Yim(Medical College of Wisconsin), Ashley M. Cunningham(Medical College of Wisconsin), Mehdi Hamadani(Medical College of Wisconsin), Timothy S. Fenske(Medical College of Wisconsin), Boro Dropulić(Miltenyi Biotec (Germany)), Rimas J. Orentas(University of Washington), Parameswaran Hari(Medical College of Wisconsin)
Cited by 454
Abstract
Related Papers
No related papers found
Powered by citation graph analysis